Emergent BioSolutions to pay $270M for vaccine maker

Emergent BioSolutions, a Gaithersburg-based pharmaceutical company that provides infectious disease vaccines for the U.S. government, is about to add cholera and typhoid vaccines to its arsenal. The company announced Thursday that it is spending $270 million cash to acquire PaxVax, a specialty vaccine manufacturer that sells Vivotif and Vaxchora, FDA-approved vaccines that protect against typhoid and ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *